Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Mylan Inc    MYL   US6285301072

MYLAN INC (MYL)

52
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/25/2014 07/28/2014 07/29/2014 07/30/2014 07/31/2014 Date
51.74(c) 50.53(c) 50.4(c) 50.55(c) 49.37 Last
3 937 926 5 227 822 8 784 645 4 335 621 4 390 513 Volume
-0.31% -2.34% -0.26% +0.30% -2.33% Change
More quotes
Company
Mylan, Inc. is a generic and specialty pharmaceuticals company, through its subsidiaries, which develops, manufactures, markets and distributes pharmaceuticals. The company operates its business through two segments: Generics & Specialty. The Generics segment primarily develops, manufactures, sells... 
Sector
Pharmaceuticals
Calendar
08/07Earnings Release
Surperformance© rating of Mylan Inc
Trading Rating : Investor Rating :
More about the company
Chart MYLAN INC
Duration : Period :
Mylan Inc Technical Analysis Chart | MYL | US6285301072 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 7 769 M
EBIT 2014 2 018 M
Net income 2014 1 112 M
Debt 2014 6 063 M
Yield 2014 -
Sales 2015 8 853 M
EBIT 2015 2 446 M
Net income 2015 1 450 M
Debt 2015 4 729 M
Yield 2015 -
PER 2014 19,11
PER 2015 14,37
EV / Sales 2014 3,21x
EV / Sales 2015 2,67x
Capitalization 18 892 M
More Financials
Latest news on MYLAN INC
19h ago MYLAN : Wins Motion for Temporary Restraining Order Against Apotex for Authorize..
07/23 MYLAN : Patent Issued for Stabilized Tolterodine Tartrate Formulations
07/23 MYLAN : To Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Gen..
07/23 MYLAN : Wins Motion to Enjoin GlaxoSmithKline from Providing Paroxetine CR to Ap..
07/23 MYLAN : Wins Motion for Temporary Restraining Order Against Apotex for Authorize..
07/22 EXCLUSIVE - INDIA'S LUPIN, U.S. FIRM : sources
07/22 India's Lupin, U.S. firms weigh bids for GSK's mature drugs -sources
07/19DJRoche Not Interested in Large Acquisitions, Says CEO -- Report
07/18 MYLAN : More Tax Inversions: Abbott Selling Part of Generic Drug Business to Myl..
07/17 MYLAN : Says It Wins Motion To Enjoin GSK From Providing Paroxetine CR To Apotex
07/17 MYLAN : Wins Motion to Enjoin GlaxoSmithKline from Providing Paroxetine CR to Ap..
07/16 MYLAN : Launches Generic Micardis® Tablets
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Technical analysis
Income Statement Evolution
Mylan Inc : Income Statement Evolution
More Financials
EPS Revisions
Mylan Inc : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF